India’s First Paper-Strip Covid Test provides accurate and low-cost testing to detect Covid-19 in less than 30 minutes and will go a long way in regulating continuous functioning of business.
To support the expansion of COVID-19 testing and contact tracing across India, The Rockefeller Foundation announced two new grants to The Centre for Cellular and Molecular Platforms and PATH.
A relationship that germinated from the days of the Vietnam War and stood the test of time has now been cemented by the coronavirus crisis and emerged as a bedrock of counterbalance in the South China Sea region including the setting up of platforms to grow trade ties further.
The new collaboration is a step forward in rolling out an additional 100 million doses of safe and effective Covid-19 vaccines for low and middle-income countries.
A new smartphone app to boost the UK’s track and trace system to help control coronavirus transmissions is being rolled out across England and Wales this week, with multiple language options, including Indian languages such as Gujarati, Punjabi and Bengali.
India is being nudged towards adopting a cycle-friendly strategy similar to the UK’s as a means of combating obesity, which has been linked with an increased risk of complication from Covid-19.
British Indian surgeon Ajith George, working with a colleague, has created an innovative new Covid-safe face mask to protect fellow ear, nose and throat (ENT) medics from coronavirus infections in the line of duty.
Necessity has been the mother of invention in the response to the COVID-19 pandemic, and nowhere is this more apparent than in India. With a clear focus on affordability and low cost, here is how frugal Indian innovations have taken the commercial route to aid the fight against pandemic.
The UK has begun human trials of a new antibody treatment for patients hospitalised with Covid-19. As part of the government-backed Randomised Evaluation of Covid-19 therapy (RECOVERY) Trials, monoclonal antibodies, or potent laboratory-made antibodies, will be given to about 2,000 patients in the coming weeks to see if they are effective against coronavirus. The Phase 3 open-label trial in patients hospitalised with Covid-19 will compare the effects of adding REGN-COV2 to the usual standard-of-care versus standard-of-care on its own.
Unlike PCR or antibody tests, antigen tests quickly detect highly infectious individuals with a high viral load, who might be super-spreaders. That’s the reason why more Indian states are now opting for them.